identification | nb exons | type | bp | product
|
Protein | kDa | AA | specific expression | Year | Pubmed
|
| 17
|
-
| 3862
|
| 95.3
| 888
| -
| 2004
| 15177567
|
| being a type I transmembrane protein |
| -
|
splicing
| 2005
|
| 57.5
| 517
| -
| 2004
| 15177567
|
| lacking the 3' portion of exon 12 through the 5' portion of exon 16 of variant SEMA6B3, a sequence that includes the stop codon used by SEMA6B3 having a different C-terminal sequence than SEMA6B3 lacking a transmembrane domain and is thought to be secreted |
| -
|
splicing
| 2500
|
| 74.6
| 682
| -
| 2004
| 15177567
|
| lacking 1305 nt that are present within the last exon (16) of variant SEMA6B3, a sequence that includes the stop codon used by SEMA6B3 having a transmembrane domain |
| -
|
-
| -
|
| -
| -
| localized to the endoplasmic reticulum and plasma membrane, in breast cancer
| 2013
| 23665584
|
| has a novel splice junction, created by the usage of alternative donor and acceptor splice sites internal to the exon 17 lacks the cytoplasmic tail, crucial for triggering the reverse signaling described for the transmembrane semaphorins |